EQ-PRC LC WARFARIN GENOTYPING KIT
Feb 2009
464d
Trimgen Corporation has submitted 1 FDA 510(k) premarket notifications since 2009, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Cytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System . Use the specialty filter in the sidebar to narrow results.